Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor

The retinoblastoma tumor suppressor protein (pRB) is a major regulator of cell-cycle progression and cellular differentiation. Central to pRB function is the pocket domain, which serves as the main binding region for cellular regulators. In tumors pRB is frequently inactivated by mutations in the po...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2005-05, Vol.24 (23), p.3810-3818
Hauptverfasser: Ledl, Andreas, Schmidt, Darja, Müller, Stefan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3818
container_issue 23
container_start_page 3810
container_title Oncogene
container_volume 24
creator Ledl, Andreas
Schmidt, Darja
Müller, Stefan
description The retinoblastoma tumor suppressor protein (pRB) is a major regulator of cell-cycle progression and cellular differentiation. Central to pRB function is the pocket domain, which serves as the main binding region for cellular regulators. In tumors pRB is frequently inactivated by mutations in the pocket domain or by binding of viral oncoproteins to this region. A characteristic feature of these viral oncoproteins and many cellular pRB-binding partners is an LxCxE sequence motif, which interacts with pRB's pocket domain. Here, we show that the ubiquitin-like modifier SUMO is covalently attached to a distinct residue (K720) of pRB within the B-box of the pocket region that binds LxCxE-motif proteins. We provide evidence that SUMO preferentially targets the active, hypophosphorylated form of pRB and show that tumorigenic mutations of pRB in the pocket domain lead to a loss of SUMOylation. Notably, the level of pRB SUMOylation is controlled by the interaction of pRB with viral and cellular LxCxE-motif proteins. Inhibitors of pRB function, including the viral oncoproteins E1A and E7 and the cellular E1A-like inhibitor of differentiation EID-1, completely abolish SUMO modification of pRB. Conversely, pRB mutants deficient in binding of LxCxE-motif proteins exhibit a drastically enhanced modification by SUMO. Finally, we provide evidence that SUMOylation can influence pRB function, as the SUMO-deficient pRB K720R mutant exerts a slightly higher repressive potential on an E2F-responsive reporter gene than wild-type pRB. Taken together, these data identify SUMO modification as a novel post-translational modification of pRB that may control pRB activity by modulating LxCxE–pocket interactions.
doi_str_mv 10.1038/sj.onc.1208539
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_67870324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A189068626</galeid><sourcerecordid>A189068626</sourcerecordid><originalsourceid>FETCH-LOGICAL-c594t-f19a278412705e6360e6f74dca594b40937441437dc52267844e3cc90e6e0ef63</originalsourceid><addsrcrecordid>eNqF0s2LEzEUAPAgiltXrx4luOhtuvnO5FhK_YDKHnS9hjSTrCkzSU1mYPWvN9sOFoRFcniQ_N5LHnkAvMZoiRFtr8t-maJdYoJaTtUTsMBMioZzxZ6CBVIcNYpQcgFelLJHCEmFyHNwgXmLBJZkAX5_D9n0sNZIh5xGF2KBG7yCJnZwI4_Bur6fepPh9n59v4F_WXaH7EqBX2-_3MAhdcEHa8aQIkwejj9cBWOIadebMqbBwHEaUoZlOhzTUn4JnnnTF_dqjpfg9sPm2_pTs735-Hm92ja2djE2HitDZMswkYg7QQVywkvWWVOPdwwpKhnDjMrOckJElcxRa1VlDjkv6CV4f6pbX_5zcmXUQygPTZno0lR0TZGIEvZfiCVTEh_h1T9wn6YcaxOaCIYpR0yoqt4-qoiknBOOK1qe0J3pnQ7RpzEbW1fnhmBTdD7U_RVuFRKtIOKcYHMqJTuvDzkMJv_SGOmHkdBlr-t36nkkasKb-RnTbnDdmc8zUMG7GZhiTe-ziTaUsxMtQYLx6q5PrtSjeOfyuZ9Hrv4DwIzNSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227355251</pqid></control><display><type>article</type><title>Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Nature Journals Online</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ledl, Andreas ; Schmidt, Darja ; Müller, Stefan</creator><creatorcontrib>Ledl, Andreas ; Schmidt, Darja ; Müller, Stefan</creatorcontrib><description>The retinoblastoma tumor suppressor protein (pRB) is a major regulator of cell-cycle progression and cellular differentiation. Central to pRB function is the pocket domain, which serves as the main binding region for cellular regulators. In tumors pRB is frequently inactivated by mutations in the pocket domain or by binding of viral oncoproteins to this region. A characteristic feature of these viral oncoproteins and many cellular pRB-binding partners is an LxCxE sequence motif, which interacts with pRB's pocket domain. Here, we show that the ubiquitin-like modifier SUMO is covalently attached to a distinct residue (K720) of pRB within the B-box of the pocket region that binds LxCxE-motif proteins. We provide evidence that SUMO preferentially targets the active, hypophosphorylated form of pRB and show that tumorigenic mutations of pRB in the pocket domain lead to a loss of SUMOylation. Notably, the level of pRB SUMOylation is controlled by the interaction of pRB with viral and cellular LxCxE-motif proteins. Inhibitors of pRB function, including the viral oncoproteins E1A and E7 and the cellular E1A-like inhibitor of differentiation EID-1, completely abolish SUMO modification of pRB. Conversely, pRB mutants deficient in binding of LxCxE-motif proteins exhibit a drastically enhanced modification by SUMO. Finally, we provide evidence that SUMOylation can influence pRB function, as the SUMO-deficient pRB K720R mutant exerts a slightly higher repressive potential on an E2F-responsive reporter gene than wild-type pRB. Taken together, these data identify SUMO modification as a novel post-translational modification of pRB that may control pRB activity by modulating LxCxE–pocket interactions.</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/sj.onc.1208539</identifier><identifier>PMID: 15806172</identifier><identifier>CODEN: ONCNES</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Adenovirus E1A Proteins - physiology ; Amino Acid Motifs ; Amino Acid Sequence ; Apoptosis ; Biological and medical sciences ; Cancer ; Cell Biology ; Cell Cycle Proteins - genetics ; Cell differentiation ; Cell Line ; Cell physiology ; Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes ; DNA-Binding Proteins - genetics ; E2F protein ; E2F Transcription Factors ; Enzymes ; Fundamental and applied biological sciences. Psychology ; Genes ; Human Genetics ; Humans ; Internal Medicine ; Kinases ; Lysine - metabolism ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Molecular and cellular biology ; Molecular Sequence Data ; Mutants ; Mutation ; Oncogene Proteins, Viral - physiology ; Oncology ; Oncoproteins ; Ophthalmology ; original-paper ; Phosphorylation ; Post-translation ; Protein Processing, Post-Translational ; Proteins ; Reporter gene ; Retina ; Retinoblastoma ; Retinoblastoma Protein - metabolism ; Retinopathies ; Signal transduction ; SUMO protein ; SUMO-1 Protein - metabolism ; Transcription factors ; Transcription Factors - genetics ; Tumor suppressor genes ; Tumors ; Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus ; Ubiquitin</subject><ispartof>Oncogene, 2005-05, Vol.24 (23), p.3810-3818</ispartof><rights>Springer Nature Limited 2005</rights><rights>2005 INIST-CNRS</rights><rights>COPYRIGHT 2005 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group May 26, 2005</rights><rights>Nature Publishing Group 2005.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c594t-f19a278412705e6360e6f74dca594b40937441437dc52267844e3cc90e6e0ef63</citedby><cites>FETCH-LOGICAL-c594t-f19a278412705e6360e6f74dca594b40937441437dc52267844e3cc90e6e0ef63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.onc.1208539$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.onc.1208539$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16820645$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15806172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ledl, Andreas</creatorcontrib><creatorcontrib>Schmidt, Darja</creatorcontrib><creatorcontrib>Müller, Stefan</creatorcontrib><title>Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor</title><title>Oncogene</title><addtitle>Oncogene</addtitle><addtitle>Oncogene</addtitle><description>The retinoblastoma tumor suppressor protein (pRB) is a major regulator of cell-cycle progression and cellular differentiation. Central to pRB function is the pocket domain, which serves as the main binding region for cellular regulators. In tumors pRB is frequently inactivated by mutations in the pocket domain or by binding of viral oncoproteins to this region. A characteristic feature of these viral oncoproteins and many cellular pRB-binding partners is an LxCxE sequence motif, which interacts with pRB's pocket domain. Here, we show that the ubiquitin-like modifier SUMO is covalently attached to a distinct residue (K720) of pRB within the B-box of the pocket region that binds LxCxE-motif proteins. We provide evidence that SUMO preferentially targets the active, hypophosphorylated form of pRB and show that tumorigenic mutations of pRB in the pocket domain lead to a loss of SUMOylation. Notably, the level of pRB SUMOylation is controlled by the interaction of pRB with viral and cellular LxCxE-motif proteins. Inhibitors of pRB function, including the viral oncoproteins E1A and E7 and the cellular E1A-like inhibitor of differentiation EID-1, completely abolish SUMO modification of pRB. Conversely, pRB mutants deficient in binding of LxCxE-motif proteins exhibit a drastically enhanced modification by SUMO. Finally, we provide evidence that SUMOylation can influence pRB function, as the SUMO-deficient pRB K720R mutant exerts a slightly higher repressive potential on an E2F-responsive reporter gene than wild-type pRB. Taken together, these data identify SUMO modification as a novel post-translational modification of pRB that may control pRB activity by modulating LxCxE–pocket interactions.</description><subject>Adenovirus E1A Proteins - physiology</subject><subject>Amino Acid Motifs</subject><subject>Amino Acid Sequence</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>Cell Cycle Proteins - genetics</subject><subject>Cell differentiation</subject><subject>Cell Line</subject><subject>Cell physiology</subject><subject>Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes</subject><subject>DNA-Binding Proteins - genetics</subject><subject>E2F protein</subject><subject>E2F Transcription Factors</subject><subject>Enzymes</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genes</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Lysine - metabolism</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Molecular and cellular biology</subject><subject>Molecular Sequence Data</subject><subject>Mutants</subject><subject>Mutation</subject><subject>Oncogene Proteins, Viral - physiology</subject><subject>Oncology</subject><subject>Oncoproteins</subject><subject>Ophthalmology</subject><subject>original-paper</subject><subject>Phosphorylation</subject><subject>Post-translation</subject><subject>Protein Processing, Post-Translational</subject><subject>Proteins</subject><subject>Reporter gene</subject><subject>Retina</subject><subject>Retinoblastoma</subject><subject>Retinoblastoma Protein - metabolism</subject><subject>Retinopathies</subject><subject>Signal transduction</subject><subject>SUMO protein</subject><subject>SUMO-1 Protein - metabolism</subject><subject>Transcription factors</subject><subject>Transcription Factors - genetics</subject><subject>Tumor suppressor genes</subject><subject>Tumors</subject><subject>Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus</subject><subject>Ubiquitin</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqF0s2LEzEUAPAgiltXrx4luOhtuvnO5FhK_YDKHnS9hjSTrCkzSU1mYPWvN9sOFoRFcniQ_N5LHnkAvMZoiRFtr8t-maJdYoJaTtUTsMBMioZzxZ6CBVIcNYpQcgFelLJHCEmFyHNwgXmLBJZkAX5_D9n0sNZIh5xGF2KBG7yCJnZwI4_Bur6fepPh9n59v4F_WXaH7EqBX2-_3MAhdcEHa8aQIkwejj9cBWOIadebMqbBwHEaUoZlOhzTUn4JnnnTF_dqjpfg9sPm2_pTs735-Hm92ja2djE2HitDZMswkYg7QQVywkvWWVOPdwwpKhnDjMrOckJElcxRa1VlDjkv6CV4f6pbX_5zcmXUQygPTZno0lR0TZGIEvZfiCVTEh_h1T9wn6YcaxOaCIYpR0yoqt4-qoiknBOOK1qe0J3pnQ7RpzEbW1fnhmBTdD7U_RVuFRKtIOKcYHMqJTuvDzkMJv_SGOmHkdBlr-t36nkkasKb-RnTbnDdmc8zUMG7GZhiTe-ziTaUsxMtQYLx6q5PrtSjeOfyuZ9Hrv4DwIzNSA</recordid><startdate>20050526</startdate><enddate>20050526</enddate><creator>Ledl, Andreas</creator><creator>Schmidt, Darja</creator><creator>Müller, Stefan</creator><general>Nature Publishing Group UK</general><general>Nature Publishing</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20050526</creationdate><title>Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor</title><author>Ledl, Andreas ; Schmidt, Darja ; Müller, Stefan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c594t-f19a278412705e6360e6f74dca594b40937441437dc52267844e3cc90e6e0ef63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenovirus E1A Proteins - physiology</topic><topic>Amino Acid Motifs</topic><topic>Amino Acid Sequence</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>Cell Cycle Proteins - genetics</topic><topic>Cell differentiation</topic><topic>Cell Line</topic><topic>Cell physiology</topic><topic>Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes</topic><topic>DNA-Binding Proteins - genetics</topic><topic>E2F protein</topic><topic>E2F Transcription Factors</topic><topic>Enzymes</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genes</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Lysine - metabolism</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Molecular and cellular biology</topic><topic>Molecular Sequence Data</topic><topic>Mutants</topic><topic>Mutation</topic><topic>Oncogene Proteins, Viral - physiology</topic><topic>Oncology</topic><topic>Oncoproteins</topic><topic>Ophthalmology</topic><topic>original-paper</topic><topic>Phosphorylation</topic><topic>Post-translation</topic><topic>Protein Processing, Post-Translational</topic><topic>Proteins</topic><topic>Reporter gene</topic><topic>Retina</topic><topic>Retinoblastoma</topic><topic>Retinoblastoma Protein - metabolism</topic><topic>Retinopathies</topic><topic>Signal transduction</topic><topic>SUMO protein</topic><topic>SUMO-1 Protein - metabolism</topic><topic>Transcription factors</topic><topic>Transcription Factors - genetics</topic><topic>Tumor suppressor genes</topic><topic>Tumors</topic><topic>Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus</topic><topic>Ubiquitin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ledl, Andreas</creatorcontrib><creatorcontrib>Schmidt, Darja</creatorcontrib><creatorcontrib>Müller, Stefan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ledl, Andreas</au><au>Schmidt, Darja</au><au>Müller, Stefan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><addtitle>Oncogene</addtitle><date>2005-05-26</date><risdate>2005</risdate><volume>24</volume><issue>23</issue><spage>3810</spage><epage>3818</epage><pages>3810-3818</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><coden>ONCNES</coden><abstract>The retinoblastoma tumor suppressor protein (pRB) is a major regulator of cell-cycle progression and cellular differentiation. Central to pRB function is the pocket domain, which serves as the main binding region for cellular regulators. In tumors pRB is frequently inactivated by mutations in the pocket domain or by binding of viral oncoproteins to this region. A characteristic feature of these viral oncoproteins and many cellular pRB-binding partners is an LxCxE sequence motif, which interacts with pRB's pocket domain. Here, we show that the ubiquitin-like modifier SUMO is covalently attached to a distinct residue (K720) of pRB within the B-box of the pocket region that binds LxCxE-motif proteins. We provide evidence that SUMO preferentially targets the active, hypophosphorylated form of pRB and show that tumorigenic mutations of pRB in the pocket domain lead to a loss of SUMOylation. Notably, the level of pRB SUMOylation is controlled by the interaction of pRB with viral and cellular LxCxE-motif proteins. Inhibitors of pRB function, including the viral oncoproteins E1A and E7 and the cellular E1A-like inhibitor of differentiation EID-1, completely abolish SUMO modification of pRB. Conversely, pRB mutants deficient in binding of LxCxE-motif proteins exhibit a drastically enhanced modification by SUMO. Finally, we provide evidence that SUMOylation can influence pRB function, as the SUMO-deficient pRB K720R mutant exerts a slightly higher repressive potential on an E2F-responsive reporter gene than wild-type pRB. Taken together, these data identify SUMO modification as a novel post-translational modification of pRB that may control pRB activity by modulating LxCxE–pocket interactions.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>15806172</pmid><doi>10.1038/sj.onc.1208539</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2005-05, Vol.24 (23), p.3810-3818
issn 0950-9232
1476-5594
language eng
recordid cdi_proquest_miscellaneous_67870324
source MEDLINE; SpringerLink Journals; Nature Journals Online; EZB-FREE-00999 freely available EZB journals
subjects Adenovirus E1A Proteins - physiology
Amino Acid Motifs
Amino Acid Sequence
Apoptosis
Biological and medical sciences
Cancer
Cell Biology
Cell Cycle Proteins - genetics
Cell differentiation
Cell Line
Cell physiology
Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes
DNA-Binding Proteins - genetics
E2F protein
E2F Transcription Factors
Enzymes
Fundamental and applied biological sciences. Psychology
Genes
Human Genetics
Humans
Internal Medicine
Kinases
Lysine - metabolism
Medical sciences
Medicine
Medicine & Public Health
Molecular and cellular biology
Molecular Sequence Data
Mutants
Mutation
Oncogene Proteins, Viral - physiology
Oncology
Oncoproteins
Ophthalmology
original-paper
Phosphorylation
Post-translation
Protein Processing, Post-Translational
Proteins
Reporter gene
Retina
Retinoblastoma
Retinoblastoma Protein - metabolism
Retinopathies
Signal transduction
SUMO protein
SUMO-1 Protein - metabolism
Transcription factors
Transcription Factors - genetics
Tumor suppressor genes
Tumors
Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus
Ubiquitin
title Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T04%3A08%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Viral%20oncoproteins%20E1A%20and%20E7%20and%20cellular%20LxCxE%20proteins%20repress%20SUMO%20modification%20of%20the%20retinoblastoma%20tumor%20suppressor&rft.jtitle=Oncogene&rft.au=Ledl,%20Andreas&rft.date=2005-05-26&rft.volume=24&rft.issue=23&rft.spage=3810&rft.epage=3818&rft.pages=3810-3818&rft.issn=0950-9232&rft.eissn=1476-5594&rft.coden=ONCNES&rft_id=info:doi/10.1038/sj.onc.1208539&rft_dat=%3Cgale_proqu%3EA189068626%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227355251&rft_id=info:pmid/15806172&rft_galeid=A189068626&rfr_iscdi=true